PT2686002T - Método para reduzir sintomas gripais associados à administração intramuscular de interferon utilizando um regime de dosagem crescente de titulação rápida - Google Patents

Método para reduzir sintomas gripais associados à administração intramuscular de interferon utilizando um regime de dosagem crescente de titulação rápida

Info

Publication number
PT2686002T
PT2686002T PT127194876T PT12719487T PT2686002T PT 2686002 T PT2686002 T PT 2686002T PT 127194876 T PT127194876 T PT 127194876T PT 12719487 T PT12719487 T PT 12719487T PT 2686002 T PT2686002 T PT 2686002T
Authority
PT
Portugal
Prior art keywords
titulation
rapid
symptoms associated
intramuscular administration
reducing fluid
Prior art date
Application number
PT127194876T
Other languages
English (en)
Portuguese (pt)
Inventor
Deykin Aaron
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of PT2686002T publication Critical patent/PT2686002T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
PT127194876T 2011-03-15 2012-03-15 Método para reduzir sintomas gripais associados à administração intramuscular de interferon utilizando um regime de dosagem crescente de titulação rápida PT2686002T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161452807P 2011-03-15 2011-03-15
US201161476930P 2011-04-19 2011-04-19

Publications (1)

Publication Number Publication Date
PT2686002T true PT2686002T (pt) 2018-04-23

Family

ID=46045072

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127194876T PT2686002T (pt) 2011-03-15 2012-03-15 Método para reduzir sintomas gripais associados à administração intramuscular de interferon utilizando um regime de dosagem crescente de titulação rápida

Country Status (25)

Country Link
US (6) US9198955B2 (https=)
EP (1) EP2686002B1 (https=)
JP (2) JP6279905B2 (https=)
KR (1) KR102050339B1 (https=)
CN (1) CN103702680A (https=)
AU (1) AU2012229104B2 (https=)
BR (1) BR112013023609A8 (https=)
CA (1) CA2846786C (https=)
CY (1) CY1120176T1 (https=)
DK (1) DK2686002T3 (https=)
EA (1) EA028448B1 (https=)
ES (1) ES2666850T3 (https=)
HR (1) HRP20180621T1 (https=)
HU (1) HUE036931T2 (https=)
IL (1) IL228425A (https=)
LT (1) LT2686002T (https=)
MX (1) MX359947B (https=)
PL (1) PL2686002T3 (https=)
PT (1) PT2686002T (https=)
RS (1) RS57175B1 (https=)
SG (1) SG193446A1 (https=)
SI (1) SI2686002T1 (https=)
SM (1) SMT201800221T1 (https=)
WO (1) WO2012125809A1 (https=)
ZA (1) ZA201306933B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012229104B2 (en) * 2011-03-15 2017-03-16 Biogen Ma Inc. Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
EP3092305B1 (en) * 2014-01-09 2023-08-02 Kyushu University, National University Corporation Method of producing microglial cells
US11266344B2 (en) 2016-09-21 2022-03-08 Samsung Electronics Co., Ltd. Method for measuring skin condition and electronic device therefor
CN116391233A (zh) * 2020-09-30 2023-07-04 皇家飞利浦有限公司 用于执行剂量滴定的方法和系统

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456748A (en) 1981-02-23 1984-06-26 Genentech, Inc. Hybrid human leukocyte interferons
EP0070906B1 (en) 1981-02-04 1986-10-15 Juridical Foundation Japanese Foundation For Cancer Research Human interferon-beta gene
US4695543A (en) 1982-03-23 1987-09-22 Bristol-Myers Company Alpha Interferon GX-1
CA1302320C (en) 1984-06-11 1992-06-02 Hideo Niwa Expression of human cromosomal interferon-_ in animal cells
US5231176A (en) 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
FI90990C (fi) 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
EP0205404B1 (en) 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
US5641656A (en) 1993-10-22 1997-06-24 University Of Connecticut Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them
JP4878664B2 (ja) * 1996-12-24 2012-02-15 バイオジェン・アイデック・エムエイ・インコーポレイテッド 安定な液体インターフェロン処方物
JP2001104482A (ja) * 1999-10-07 2001-04-17 Terumo Corp ２室型プレフィルドシリンジ
WO2004069302A2 (en) * 2003-01-30 2004-08-19 Becton, Dickinson And Company Holder with safety shield for a drug delivery device
UA92146C2 (ru) * 2004-06-01 2010-10-11 Эйрэс Трейдинг С.А. Стабилизированная жидкая композиция, которая содержит интерферон
US20060089593A1 (en) * 2004-10-26 2006-04-27 Sergio Landau Needle-free injection device for individual users
EP1923085A1 (en) * 2006-11-17 2008-05-21 Sanofi-Aventis Deutschland GmbH Dosing and drive mechanism for drug delivery device
AU2007333959A1 (en) 2006-12-18 2008-06-26 Altus Pharmaceuticals Inc. Human growth hormone formulations
US9044378B2 (en) * 2007-05-31 2015-06-02 Safety Syringes, Inc. Anti-needle stick safety device or system for use with drugs requiring reconstitution
JP5549048B2 (ja) * 2007-08-16 2014-07-16 味の素株式会社 薬剤バイアルとプレフィルドシリンジの接続構造
AU2010263058A1 (en) * 2009-06-18 2012-01-12 Wyeth Llc Lyophilized formulations for small modular immunopharmaceuticals
AU2012229104B2 (en) * 2011-03-15 2017-03-16 Biogen Ma Inc. Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen

Also Published As

Publication number Publication date
US10500254B2 (en) 2019-12-10
US20170360890A1 (en) 2017-12-21
SI2686002T1 (en) 2018-06-29
SG193446A1 (en) 2013-10-30
US9198955B2 (en) 2015-12-01
EA028448B1 (ru) 2017-11-30
US20250276042A1 (en) 2025-09-04
KR102050339B1 (ko) 2019-11-29
BR112013023609A2 (pt) 2016-12-06
IL228425A (en) 2017-08-31
CA2846786C (en) 2022-05-17
IL228425A0 (en) 2013-12-31
BR112013023609A8 (pt) 2018-04-03
CA2846786A1 (en) 2012-09-20
KR20140038383A (ko) 2014-03-28
CY1120176T1 (el) 2018-12-12
LT2686002T (lt) 2018-05-10
US20200046804A1 (en) 2020-02-13
NZ616536A (en) 2015-10-30
JP6279905B2 (ja) 2018-02-14
WO2012125809A1 (en) 2012-09-20
AU2012229104A1 (en) 2013-10-03
HRP20180621T1 (hr) 2018-07-27
NZ712273A (en) 2016-09-30
RS57175B1 (sr) 2018-07-31
US20160101157A1 (en) 2016-04-14
SMT201800221T1 (it) 2018-07-17
PL2686002T3 (pl) 2018-10-31
MX359947B (es) 2018-10-17
ES2666850T3 (es) 2018-05-08
MX2013010507A (es) 2014-04-30
EA201301024A1 (ru) 2014-03-31
DK2686002T3 (en) 2018-04-30
JP6522069B2 (ja) 2019-05-29
ZA201306933B (en) 2016-07-27
AU2012229104B2 (en) 2017-03-16
JP2014508174A (ja) 2014-04-03
HUE036931T2 (hu) 2018-08-28
EP2686002B1 (en) 2018-01-24
US20220280610A1 (en) 2022-09-08
JP2018030847A (ja) 2018-03-01
US20120237479A1 (en) 2012-09-20
CN103702680A (zh) 2014-04-02
EP2686002A1 (en) 2014-01-22

Similar Documents

Publication Publication Date Title
DK3603732T3 (da) Medikamentleveringssystem med en forsinkelsesmekanisme
DK3329965T3 (da) Doseringsregime for anti-alpha4beta7-antistof
DK2701773T3 (da) Dosisstyredele til injektionssprøjte
BR112012009778A2 (pt) regime de dosagem para administrar um anticorpo biespecífico de cd19xcd3
BR112013018900A2 (pt) conjuntos para uma estrutura
PT2672973T (pt) Regime de administração para nitrocatecóis
BR112014016062A2 (pt) método para fabricação de um artigo limpável, artigo limpável e método para utilizar um artigo limpável
ES2746233T8 (es) Vacunas individualizadas para el cáncer
BR112014004960A2 (pt) mecanismo de inserção para uma bomba de administração de fármaco
BR112014003798A2 (pt) método para fabricar um composto, e, composto
DK2665503T3 (da) Medikamenttilførselsanordning
EP2667915A4 (en) INJEKTOR
BR112014001346A2 (pt) composto nanotransportador, método, composto farmacêutico e uso de um composto
SMT201500209B (it) Forme di dosaggio farmaceutiche a rilascio controllato
ZA201403288B (en) Valve for administration of a plurality of drug fluids
BR112013029138A2 (pt) procedimento para assinatura digital múltipla
BR112014008603A2 (pt) tablete, e, método para produzir um tablete
BR112013014546A2 (pt) dispositivo e método para administração de um dispositivo vascular
IL231622B (en) Pharmaceutical composition for treatment of cachexia
PT2772261T (pt) Adsorvente administrado oralmente
BR112013019917A2 (pt) dispositivo para uma válvula
HUE039907T2 (hu) Gyógyszer-szállító technológia
BR112014015469A2 (pt) método para controlar uma disposição de bomba
BR112014005307A2 (pt) artigo resistente balístico, método para produzir um artigo resistente balístico
FR2976587B1 (fr) Methode de dosage in vitro par technique immunologique